Companies: 10,795·Total market cap: $144.5T
Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSENASDAQHealthcare● Active
$24.84
$-0.49(-1.93%)
Market Cap$1.7B
P/E Ratio
52W High$27.98
52W Low$12.56
Overview

Pulse Biosciences, Inc. (PLSE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PLSE · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.09plse eps ttm · plse earnings per shareEarnings history
PE Ratio (TTM)plse pe ratio ttm · plse price to earningsPE Ratio deep dive
Revenue (TTM)751000.00plse revenue ttm · plse annual revenueFull revenue history
Dividend YieldNo Dividenddoes plse pay dividends · plse dividend yieldDividend history
Shares Outstanding67.4Mplse shares outstanding · plse floatShares outstanding history
Next EarningsAug 11, 2026Est.plse earnings date · plse next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$350000.00
202320242025
pulse biosciences, inc. revenue · plse revenue 2025
FY 2025Net Income-$72.8M▼ 35.82% YoY
202320242025
pulse biosciences, inc. net income · plse profit 2025
FY 2025EPS$-1.08▼ 17.39% YoY
202320242025
plse eps · pulse biosciences, inc. earnings per share 2025
TTM:Revenue: $751000.00Net Income: -$74.6MEPS: $-1.09View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis plse a buy · plse analyst rating
Strong Buy
0
Buy
2
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$30.00Low
$24.84Current
$30.67Avg Target23.47% upside
$32.00High
plse price target · plse 12 month forecast

Total: 4 · Buy rate: 50.0%

The PLSE analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $30.67, representing +23.47% upside from the current price of $24.84.

Stock Performance

Full History
1D-1.93%
1W+2.35%
1M+30.19%
3M+36.93%
YTD+80.92%
1Y+43.67%
5Y+37.39%

About Pulse Biosciences, Inc.

CEOPaul Arthur LaViolette
IPO DateMay 18, 2016
Employees75
CountryUS

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled vi…

what is pulse biosciences, inc. · plse stock overview · pulse biosciences, inc. company profile · who is pulse biosciences, inc. ceo · plse NASDAQ · pulse biosciences, inc. headquarters · pulse biosciences, inc. business segments

About Stock Overview & Key Data

Pulse Biosciences, Inc. (PLSE) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since May 18, 2016. As of the latest trading session, PLSE stock price is $24.84, with a market capitalization of $1.7B. The stock has returned +43.67% over the past 12 months and +80.92% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Pulse Biosciences, Inc. stock is Buy, with an average 12-month price target of $30.67. In fiscal year 2025, Pulse Biosciences, Inc. reported revenue of $350000.00 and net income of -$72.8M. For detailed data — including Pulse Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Pulse Biosciences, Inc. (PLSE) stock price is $24.84. The stock is traded on NASDAQ under the ticker symbol PLSE. The 52-week range is $12.56 – $27.98.

PLSE stock pricePLSE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice